{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:25:46Z","timestamp":1765704346729,"version":"3.48.0"},"reference-count":28,"publisher":"BMJ","issue":"12","funder":[{"name":"Shanghai Eye Disease Research Center","award":["2022ZZ01003"],"award-info":[{"award-number":["2022ZZ01003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388101"],"award-info":[{"award-number":["82388101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2025,7,2]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To characterise the clinicopathological features, treatment outcomes and prognostic factors in late-onset retinoblastoma (LoRB) (\u22655 years) compared to classical-onset cases (&lt;5 years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 21 cases of LoRB and 84 matched classical-onset cases diagnosed between April 2016 and December 2023 at two tertiary retinoblastoma (RB) centres. Data on clinical presentations, histopathological features, treatment modalities and outcomes were collected and analysed between two groups. A subgroup analysis was performed based on presenting symptoms in the late-onset group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 21 patients with LoRB were diagnosed, accounting for 5.43% of all RB cases. The median age at diagnosis was 80 months. All late-onset cases presented unilaterally and were in International Intraocular Retinoblastoma Classification groups D and E. Compared with the control group, late-onset patients demonstrated significantly longer diagnostic lag times (p=0.008), a markedly lower rate of leucocoria as the presenting symptom (p&lt;0.001), a higher rate of vitreous seeding (p=0.03) and subretinal fluid (p=0.04), and shorter median globe salvage times (p=0.04). Late-onset patients with atypical onset symptoms experienced longer diagnostic lag times (p=0.05), more group E eyes at diagnosis (p=0.03) and shorter median globe salvage times (p=0.05) compared with those with classical symptoms (leucocoria and strabismus).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LoRB presents distinct clinical features and more severe manifestations, highlighting the necessity for early recognition and timely intervention of this subtype. Our findings contribute to a more comprehensive understanding of the relationship between the age of onset and RB behaviour.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2025-327750","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T21:40:22Z","timestamp":1752183622000},"page":"1402-1408","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Increased clinical risk factors and absence of leucocoria in late-onset retinoblastoma: a comparative cohort study"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7837-7115","authenticated-orcid":false,"given":"Yu","family":"Luan","sequence":"first","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingpeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-4379","authenticated-orcid":false,"given":"Xuyang","family":"Wen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglei","family":"Han","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-7451","authenticated-orcid":false,"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7442-1391","authenticated-orcid":false,"given":"Jiayan","family":"Fan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-0940","authenticated-orcid":false,"given":"Peiwei","family":"Chai","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital Department of Ophthalmology, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2025112002101389000_109.12.1402.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.139618"},{"key":"2025112002101389000_109.12.1402.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.138750"},{"key":"2025112002101389000_109.12.1402.3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ophtha.2023.10.015","article-title":"Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries","volume":"131","author":"Kaliki","year":"2024","journal-title":"Ophthalmology"},{"key":"2025112002101389000_109.12.1402.4","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries","volume":"10","author":"Fabian","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025112002101389000_109.12.1402.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.05.005"},{"key":"2025112002101389000_109.12.1402.6","doi-asserted-by":"publisher","DOI":"10.1067\/mpa.2002.120643"},{"key":"2025112002101389000_109.12.1402.7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/pbc.20931","article-title":"Retinoblastoma in children older than 5 years of age","volume":"48","author":"de Aguirre Neto","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2025112002101389000_109.12.1402.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32283-8"},{"key":"2025112002101389000_109.12.1402.9","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2010-0759-OA"},{"key":"2025112002101389000_109.12.1402.10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000509040","article-title":"Retinoblastoma in Children Older than 6 Years of Age","volume":"6","author":"Meel","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"2025112002101389000_109.12.1402.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.018"},{"key":"2025112002101389000_109.12.1402.12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2025112002101389000_109.12.1402.13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"2025112002101389000_109.12.1402.14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.24213","article-title":"Retinoblastoma, the visible CNS tumor: A review","volume":"97","author":"Dimaras","year":"2019","journal-title":"J Neurosci Res"},{"key":"2025112002101389000_109.12.1402.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2025112002101389000_109.12.1402.16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.22.02875","article-title":"Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons","volume":"42","author":"Oesterheld","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025112002101389000_109.12.1402.17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000381220","article-title":"Retinoblastoma in Chinese Children Aged Five to Fourteen Years","volume":"233","author":"Chang","year":"2015","journal-title":"Ophthalmologica"},{"key":"2025112002101389000_109.12.1402.18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8148013","article-title":"Clinical Features and Long-Term Follow-Up of Patients with Retinoblastoma in Turkish Children Older Than 5 Years of Age","volume":"2020","author":"Cebeci","year":"2020","journal-title":"J Ophthalmol"},{"key":"2025112002101389000_109.12.1402.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70045-7"},{"key":"2025112002101389000_109.12.1402.20","doi-asserted-by":"crossref","first-page":"100188","DOI":"10.1016\/j.xops.2022.100188","article-title":"High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures","volume":"2","author":"Roohollahi","year":"2022","journal-title":"Ophthalmology Science"},{"key":"2025112002101389000_109.12.1402.21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.sjopt.2019.07.008","article-title":"Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age","volume":"33","author":"Masoomian","year":"2019","journal-title":"Saudi J Ophthalmol"},{"key":"2025112002101389000_109.12.1402.22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2021.09.002","article-title":"Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China","volume":"129","author":"Zhou","year":"2022","journal-title":"Ophthalmology"},{"key":"2025112002101389000_109.12.1402.23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.5858\/133.8.1203","article-title":"High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study","volume":"133","author":"Eagle","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"2025112002101389000_109.12.1402.24","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20080101-16"},{"key":"2025112002101389000_109.12.1402.25","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn024"},{"key":"2025112002101389000_109.12.1402.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.01.041"},{"key":"2025112002101389000_109.12.1402.27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ebiom.2015.06.022","article-title":"Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression","volume":"2","author":"Kooi","year":"2015","journal-title":"EBioMedicine"},{"key":"2025112002101389000_109.12.1402.28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209622"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2025-327750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:23:59Z","timestamp":1765704239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2025-327750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bjo-2025-327750"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2025-327750","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"type":"print","value":"0007-1161"},{"type":"electronic","value":"1468-2079"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}